the Hypertrophic Scar Prevention of BMT101.
NCT04012099 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2023-05-24
Summary
An Independent Evaluator-Blind, Dose-Escalation, Untreated-Controlled, Within-Subject, Phase 2a Therapeutic Exploratory Clinical Trial
Conditions
- Hypertrophic Scar
Interventions
- DRUG
-
BMT101
Intradermal injection to each of 3 dose-groups.
Sponsors & Collaborators
-
Hugel
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 19 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-08-21
- Primary Completion
- 2023-05-10
- Completion
- 2023-05-10
Countries
- South Korea
Study Locations
More Related Trials
-
Mechanistic Basis of Ablative Carbon Dioxide Laser in Treating Hypertrophic Scars
NCT04736251 ·Status: UNKNOWN
-
Treatment of Hypertrophic Scars Using Fractional Laser and Fractional Laser-assisted Topical Corticosteroid Delivery
NCT02487212 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars)
NCT04593706 ·Status: UNKNOWN ·Phase: NA
-
Laser Treatment for the Improvement of Scars and Scleroderma
NCT04567537 ·Status: TERMINATED ·Phase: NA
-
Correlation of Early Postoperative Scar Appearance With Long-term Scar Outcomes
NCT04015453 ·Status: COMPLETED
-
Comparative Study Between Intralesional Corticosteroid Injection Alone and Combined Intralesional Corticosteroid Injection With Either Long-pluse Nd YAG or Erbium Yag for Treating Hypertrophic or Keloid Scars
NCT07263100 ·Status: COMPLETED ·Phase: NA
-
Characterization of Dyschromic Hypertrophic Scar
NCT04619589 ·Status: COMPLETED
-
10 600 nm Ablative Fractional Laser Treatment of Scars: a Prospective Single Blinded Within Patient Controlled Randomized Trial
NCT01639105 ·Status: COMPLETED ·Phase: NA
-
Tissue-engineered Skin Graft Repair of Autologous Scar Dermal Scaffolds
NCT04389164 ·Status: RECRUITING ·Phase: NA
-
Study to Evaluate Efficacy of OLX10010 in Reducing Recurrence of Hypertrophic Scarring After Scar Revision Surgery
NCT04877756 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of HO/03/03 10-40 Micro Grams to Treat Hard to Heal Wounds
NCT01772303 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Study of the Effectiveness of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Fibrin to Treat Chronic Wounds
NCT01751282 ·Status: TERMINATED ·Phase: PHASE1
-
Microneedling for Burn Hypertrophic Scars
NCT05423613 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Clinical, Perceived and Instrumental Efficacy of a Scar Gel in Preventing Hypertrophic Scars
NCT06751433 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures
NCT01564407 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Nanofat on Wound Healing and Scar Formation
NCT03850119 ·Status: UNKNOWN ·Phase: NA
-
Effect of Nd-YAG Laser on Hypertrophic Scar
NCT06347081 ·Status: COMPLETED ·Phase: NA
-
A DERMO-EPIDERMAL AUTOLOGOUS SKIN SUBSTITUTE FOR FURTHER THERAPEUTIC USE
NCT04925323 ·Status: UNKNOWN ·Phase: NA
-
Autologous Adipose Stem Cell Assisted Skin Graft
NCT04532593 ·Status: UNKNOWN ·Phase: NA
-
Effect of Extracorporeal Shock Wave Therapy for Burn Scar Charateristics
NCT04187586 ·Status: COMPLETED
-
Laser Induced Bioengineered Remodeling of Thermally Injured Skin Trial
NCT02655211 ·Status: WITHDRAWN ·Phase: NA
-
The Improving Effect of Autologous Stromal Vascular Fraction (SVF) in Adipose Tissue on Skin Grafting
NCT02546882 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
1540nm Non Ablative Fractional Laser Treatment of Scars
NCT01056211 ·Status: COMPLETED ·Phase: PHASE4
-
Hypertrophic Scarring After Facial Burn
NCT00242970 ·Status: COMPLETED
-
The Effects of Autologous Fat Transfer on Preventing Expanded Skin From Expansion Failure
NCT02809001 ·Status: COMPLETED ·Phase: PHASE1/PHASE2